Mr Hugh Mostafid



  • is fee assuredFee assured

This healthcare professional let us know that they are currently available for:

    • Phone consultations

Last updated: 12 Nov 2020

Specialises in

  • General urology
  • Urinary tract stones
  • Urological oncology


  • Video and telephone consultations

About me

Hugh Mostafid qualified from St Thomas's Hospital London in 1989 and trained at Guy's Hospital and the Institute of Urology in London. He obtained his MSc in Urology from the University of London in 1996 and won the William Cook travelling fellowship to visit Professor Skinner's unit at the University of Southern California in Los Angeles, a world renowned centre of excellence for bladder cancer. He was appointed as a consultant urologist in Basingstoke in 2001. In 2014 he moved to the regional bladder cancer service at the Royal Surrey County Hospital in Guildford which covers a population of 1.8 million and is one of the few centres in the country performing robotic-assisted radical bladder cancer surgery. In that year he was also a visiting scholar at the Department of Urology at the University of California in Los Angeles to learn robotic surgery techniques. He is also an Honorary Senior Lecturer in the Faculty of Health and Medical Sciences at the University of Surrey in Guildford.
His main clinical interests are bladder cancer, stone disease and urinary tract infection. He was one of the first UK urologists to introduce blue light cystoscopy and device assisted intravesical therapy for bladder cancer. His main research interests are the diagnosis and treatment of bladder cancer.
He is a founder member and past Chair of Bladder Cancer UK, a charity which was set up to raise funds for bladder cancer research and improve patient outcomes in the UK. He is also a past member of the National Cancer Research Institute's Bladder Cancer clinical study group, the NICE bladder cancer guidelines group and the NHS England specialised urology clinical reference group. He is the Chief Investigator for CALIBER, a national bladder cancer trial funded £360,000 by the DoH and co-applicant in many other national bladder cancer trials.
He is currently an expert advisor to NICE on bladder cancer, a member of the European Association of Urology Bladder Cancer Guideline Panel and a faculty member of the European School of Urology.
He has published over 70 papers and written book chapters on bladder cancer as well as being an invited speaker at national and international meetings on bladder cancer.

Areas of interest

Superficial bladder cancer; Photodynamic diagnosis (blue light cystoscopy); Hyperthemia for refractory superficial bladder cancer; Cystectomy including bladder reconstruction; Voiding dysfunction; Painful bladder syndrome / interstitial cystitis; Urinary tract infection; Prostatitis; Kidney stones; Lasertripsy for kidney stones; Prostatic enlargement

Medical secretaries

Anaesthetists worked with

  • Mr Hugh Mostafid has worked with Dr Peter R Gregory at the following hospitals:

    • BMI The Hampshire Clinic (1-5)
  • Mr Hugh Mostafid has worked with Dr Patrick Creagh-Barry at the following hospitals:

    • BMI The Hampshire Clinic (1-5)
  • Mr Hugh Mostafid has worked with Dr Judith Gudgeon at the following hospitals:

    • Nuffield Health Guildford Hospital (1-5)
  • Mr Hugh Mostafid has worked with Dr Girish Dhond at the following hospitals:

    • Nuffield Health Guildford Hospital (1-5)
About me
My outcomes
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

Report this page Edit details

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.